Epidermolysis Bullosa: Corrected iPS Stem Cell-Based Therapy

Posted: June 16, 2011 at 6:32 am



(Part 5 of 6) Marius Wernig, MD, spoke at the "Spotlight on Disease Team Awards: Genetic Skin Disease," an educational event presented at the CIRM Governing Board meeting on February 4, 2010. Wernig is an assistant professor of pathology at the Institute for Stem Cell Biology and Regenerative Medicine in the Stanford School of Medicine.

Go here to see the original:
Epidermolysis Bullosa: Corrected iPS Stem Cell-Based Therapy

Related Posts

Comments are closed.

Archives